We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genus Plc | LSE:GNS | London | Ordinary Share | GB0002074580 | ORD 10P |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
1,674.00 | 1,680.00 | 1,714.00 | 1,668.00 | 1,714.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 668.8M | 7.9M | 0.1196 | 140.13 | 1.11B |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
08:55:38 | O | 500 | 1,675.38 | GBX |
Date | Time | Source | Headline |
---|---|---|---|
20/11/2024 | 15:32 | UK RNS | Genus PLC Results of AGM |
20/11/2024 | 11:52 | ALNC | Genus cautiously optimistic despite limited growth ahead of AGM |
20/11/2024 | 07:00 | UK RNS | Genus PLC AGM Trading Update |
01/11/2024 | 10:42 | UK RNS | Genus PLC Total Voting Rights |
22/10/2024 | 08:17 | ALNC | IN BRIEF: Genus CFO Alison Henriksen to leave in July next year |
22/10/2024 | 06:00 | UK RNS | Genus PLC Chief Financial Officer Retirement |
14/10/2024 | 06:00 | UK RNS | Genus PLC Annual Report and Annual General Meeting |
18/9/2024 | 10:17 | UK RNS | Genus PLC Director/PDMR Shareholding |
16/9/2024 | 15:29 | UK RNS | Genus PLC Director/PDMR Shareholding |
12/9/2024 | 15:51 | UK RNS | Genus PLC Director/PDMR Shareholding |
Genus (GNS) Share Charts1 Year Genus Chart |
|
1 Month Genus Chart |
Intraday Genus Chart |
Date | Time | Title | Posts |
---|---|---|---|
20/11/2024 | 07:40 | Genus with Charts | 226 |
25/5/2005 | 16:54 | BEEF UP THAT MACHO GENUS | 43 |
24/9/2002 | 23:06 | Genus - these todger tuggers are flying | 3 |
02/9/2002 | 18:43 | Is this stock very undervalued? - any more info | 22 |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|---|---|---|---|
08:55:38 | 1,675.38 | 500 | 8,376.90 | O |
08:55:12 | 1,677.00 | 11 | 184.47 | O |
08:55:05 | 1,676.00 | 18 | 301.68 | AT |
08:55:05 | 1,676.00 | 15 | 251.40 | AT |
08:50:39 | 1,674.00 | 50 | 837.00 | AT |
Top Posts |
---|
Posted at 21/11/2024 08:20 by Genus Daily Update Genus Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GNS. The last closing price for Genus was 1,686p.Genus currently has 66,033,959 shares in issue. The market capitalisation of Genus is £1,106,729,153. Genus has a price to earnings ratio (PE ratio) of 140.13. This morning GNS shares opened at 1,714p |
Posted at 09/10/2024 15:03 by indiestu If the price holds into close then the gap from February is closed. That's very bullish for a long and steady rise as likely no sellers left in the game. It's been a little painful here for the past couple of years but maybe, just maybe it's turning. GLA holders. |
Posted at 13/8/2024 08:30 by cerrito I am not a holder here but watch.A good commentary on GNS by the Odyssean fund manager last week on Vox markets with Paul Hill. |
Posted at 10/8/2024 11:22 by edwardt The pork price rise has to be meaningful here |
Posted at 03/11/2023 12:53 by edwardt Think you are a bit optimistic there! I would say $100m with 90% margins five years out is about right for the US. This could easily be the same for China and throw in ROW and you might be near your figure. All in this could justify a tripling of the share price imho 2 to 3 years out once they start to ramp. |
Posted at 11/10/2023 09:23 by the white house Legging back in starting @ 22Decent update and long term v interesting prospects across the globeChina gov has been in the market stockpiling and boosted pork price by 25pc since JulyOne way bet from here |
Posted at 18/7/2023 12:57 by edwardt Not so fast. Let's see when they announce on their disease resistant pigs. The share price will fly... |
Posted at 13/9/2022 20:46 by cerrito I was interested to read Citywire's take of the recent Peel Hunt notequote Peel Hunt upgrades underappreciated Genus Peel Hunt has upgraded Genus (GNS), which manufactures biotech and genetics products for cattle and pig farmers, after saying it is ‘back on the front foot’. Analyst Charles Hall upgraded his recommendation from ‘hold’ to ‘buy’ but retained his target price of £45 on the stock, which shot up 16.7% to close at £27.98 on Thursday after a trading update. Full-year 2022 was a challenging year for the group, with sharp declines in its China business as pork prices slumped, combining with pressure on producers from soaring input costs. ‘The outlook in China porcine now looks more encouraging, helped by the reduction in the sow herd and rising hog prices,’ said Hall. ‘Furthermore, commodity prices are adjusting to reflect the higher input costs.’ Despite ‘strong underlying performance, improved visibility in China, and currency benefit’, the shares have ‘materially derated and there is effectively nothing in the valuation for the significant potential in gene editing, which is on track for commercialisation in full-year 2024’. Hall added ‘there is little doubt of the direction of travel for revenue prospects’ and there is ‘good cost management in place against the inflationary backdrop’. unquote |
Posted at 30/6/2021 10:34 by edwardt Chinese govt stock piling pork - should help. Pork price rallying hard. Lots and lots to like in this stock - valuation is high but that is for good reason imo. |
Posted at 09/3/2020 21:11 by thewheeliedealer Hi all,My mate Peter @Conkers3 and myself did another Podcast a few days ago and GNS was one of the Stocks that we rambled around. We also covered lots on the Markets and what we were expecting all this Virus stuff to mean. Anyway, if you use Apple or Audioboom you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 18) and you can find it on Soundcloud on the link below. Cheers, WD @wheeliedealer |
Posted at 30/10/2017 20:48 by chester I was wondering why the price increased so much today. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions